This open-label extension study is assessing the safety and local tolerance of repeated treatment cycles of AM-101 in subjects previously treated in the scope of the TACTT2 study (NCT01803646).
The purpose of this research study is to test the safety and local tolerance of repeated treatment cycles of AM-101.